Antioxidant and vitamin E transport genes and risk of high-grade prostate cancer and prostate cancer recurrence.
Antioxidant and vitamin E transport genes and risk of high-grade prostate cancer and prostate cancer recurrence.
复制标题
DOI:
10.1002/pros.22717
复制
发表时间:
2013-12
期刊:
影响因子:
--
通讯作者:
Chan JM
中科院分区:
文献类型:
--
作者:
Bauer SR;Richman EL;Sosa E;Weinberg V;Song X;Witte JS;Carroll PR;Chan JM
Observational studies suggest an inverse association between vitamin E and risk of prostate cancer, particularly aggressive tumors. However, three large randomized controlled trials have reported conflicting results. Thus, we examined circulating vitamin E and vitamin E-related genes in relation to risk of high-grade prostate cancer and prostate cancer recurrence among men initially diagnosed with clinically organ-confined disease. We measured circulating α- and γ-tocopherol and genotyped 30 SNPs in SOD1, SOD2, SOD3, TTPA, and SEC14L2 among 573 men with organ-confined prostate cancer who underwent radical prostatectomy. We examined associations between circulating vitamin E, genotypes, and risk of high-grade prostate cancer (Gleason grade ≥ 8 or 7 with primary score ≥ 4; n = 117) using logistic regression, and risk of recurrence (56 events; 3.7 years median follow-up) using Cox proportional hazards regression. Circulating γ-tocopherol was associated with an increased risk of high-grade prostate cancer (Q4 v. Q1 odds ratio [OR] = 1.87; 95% confidence intervals [CI]: 0.97–3.58; Ptrend = 0.02). The less common allele in SOD3 rs699473 was associated with an increased risk of high-grade disease (T > C: OR = 1.40, 95% CI: 1.04–1.89). Two independent SNPs in SOD1 were inversely associated with prostate cancer recurrence in additive models (rs17884057 hazard ratio [HR] = 0.49, 95%CI: 0.25–0.96; rs9967983 HR = 0.62, 95% CI: 0.40–0.95). Among men with clinically organ-confined prostate cancer, genetic variation in SOD may be associated with risk of high-grade disease at diagnosis and disease recurrence. Circulating γ-tocopherol levels may also be associated with an increased risk of high-grade disease at diagnosis.
登录
查看更多内容
影响因子:
10.3
作者:
Kirsh, VA;Hayes, RB;Peters, U
通讯作者:
Peters, U
影响因子:
4.7
作者:
Beilby, J.;Ambrosini, G. L.;Musk, A. W.
通讯作者:
Musk, A. W.
影响因子:
3.5
作者:
Hosomi, A;Arita, M;Inoue, K
通讯作者:
Inoue, K
影响因子:
2.8
作者:
Kashiwagi, Eiji;Shiota, Masaki;Naito, Seiji
通讯作者:
Naito, Seiji
影响因子:
11.2
作者:
Kumar, Binod;Koul, Sweaty;Koul, Hari K.
通讯作者:
Koul, Hari K.